ESR1 and cancer: Given the growing interest in utilizing non-toxic dietary compounds as adjuvant cancer therapies, we used the MTT cell viability assay to determine if the upregulation of ERα modulated the proliferative response of HCC38 cells to treatment with 4-OHT, which is the active metabolite of tamoxifen.